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Abstract
Inflammation, trauma or nerve injury trigger low-level activity in C-fibres and may cause long-lasting
hyperalgesia. Long-term potentiation (LTP) at synapses of primary afferent C-fibres is considered
to underlie some forms of hyperalgesia. In previous studies, high- but not low-frequency
conditioning stimulation of C-fibres has, however, been used to induce LTP in pain pathways.
Recently we could show that also conditioning low-frequency stimulation (LFS) at C-fibre intensity
induces LTP in vitro as well as in the intact animal, i.e. with tonic descending inhibition fully active.
In the slice preparation, this form of LTP requires a rise in postsynaptic Ca2+-concentration and
activation of Ca2+-dependent signalling pathways. Here, we investigated the signalling mechanisms
underlying this novel form of LTP in vivo. We found that the signal transduction pathways causing
LFS-induced LTP in vivo include activation of neurokinin 1 and N-methyl-D-aspartate receptors, rise
of [Ca2+]i from intracellular stores and via T-type voltage-dependent Ca2+ channels, activation of
phospholipase C, protein kinase C and Ca2+-calmodulin dependent kinase II. These pathways match
those leading to hyperalgesia in behaving animals and humans. We thus propose that LTP induced
by low-level activity in C-fibres may underlie some forms of hyperalgesia.
Background
LTP at the first synapse in pain pathways is considered to
underlie some forms of pain amplification e.g. after
trauma, inflammation or nerve injury [1]. A strong rise in
postsynaptic calcium ion concentration triggering Ca2+-
dependent signal transduction pathways is required for
LTP induction [2-4]. Consequently, high-frequency (~100
Hz), burst-like stimulation protocols were previously
used to induce LTP at virtually all synapses studied so far.
Low-level activity between 1–10 imp·s-1 rather than high
frequency bursts are, however, typical for C-fibre dis-
charges during inflammation, trauma or wound healing.
Presynaptic activity at these low frequencies is considered
inadequate to cause a sufficiently strong rise in postsynap-
tic [Ca2+]i for potentiation of synaptic strength. In fact,
low-level presynaptic activity was either ineffective or
induced synaptic long-term depression (LTD) rather than
LTP in previous studies.
We have recently discovered that in a spinal cord slice
preparation with long dorsal roots intact LFS of dorsal
roots at C-fibre intensity induces LTP which involves a rise
in postsynaptic [Ca2+]i and Ca2+-dependent signal trans-
duction pathways [4]. In the intact animal spinal dorsal
neurons are, however, under a powerful tonic inhibition
arising from supraspinal, descending pathways [5,6]. This
inhibition is inevitably lost in the in vitro situation and
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could thereby facilitate LTP-induction. And indeed,
removal of descending, putatively inhibitory pathways by
spinalisation is required for the induction of LTP by either
pinching or noxious heating of the skin [7]. On the other
hand, we have shown recently that in the intact animal,
LTP can be induced by LFS as well as by subcutaneous cap-
saicin or formalin injections also [4]. Here, we further
characterised this novel LFS-induced LTP at C-fibre syn-
apses in the intact animal.
Methods
Preparation of the animals
After obtaining approval from the Institutional Animal
Care Comitee (Austrian Federal Ministry for Education,
Science and Culture), experiments were performed on
adult male Sprague Dawley rats (200 – 300 g) obtained
from a local breeding facility.
Animals were intubated using a 16 G cannula and
mechanically ventilated (Siemens Servoventilator 900C).
Isoflurane in two thirds N2O and one third O2 was used to
induce (4 vol% inspiratory) and maintain (1.5 vol%
expiratory) anaesthesia. Surgical level of anaesthesia was
verified by stable arterial blood pressure and the absence
of paw withdrawal reflexes after pinching the paw. Surgi-
cal procedures have been described in more detail else-
where [4]. Briefly, the right femoral vein and artery were
cannulated to allow i.v. infusions and to monitor arterial
blood pressure. Muscle relaxation was achieved by 2
μg·kg-1·h-1  pancuronium bromide i.v The left sciatic
nerve was dissected free for bipolar electrical stimulation
using a silver hook electrode. Lumbar segments L4 and L5
were exposed by laminectomy. The dura mater was
incised and reflected. Two metal clamps were used for fix-
ation of the vertebral column in a stereotactic frame. An
agarose pool was formed around the exposed spinal seg-
ments. The spinal segments were covered with artificial
cerebrospinal fluid which was carefully removed before
application of drugs (see below). The exposed sciatic
nerve was covered with warm paraffin oil. At the end of
the experiment animals were decapitated in deep anaes-
thesia and the spinal cord removed to locate the recording
site (see next paragraph).
Electrophysiological recordings
Electrophysiological recordings were performed as
described elsewhere [4]. Briefly, C-fibre-evoked field
potentials were recorded with glass electrodes (2–3 MΩ)
in laminae I and II of the spinal cord dorsal horn in
response to stimulation of the ipsilateral sciatic nerve.
Electrodes were driven by a microstepping motor (Nar-
ishige Scientific Instrument, Japan). Recordings were
made with an ISO-DAM-amplifier (World Precision
Instruments Inc., Sarasota, FL, USA) using a band width
filter of 0.1 – 1000 Hz. Signals were monitored on a dig-
ital oscilloscope (Tektronix TDS 210) and digitized at a
sampling rate of 5 kHz by an A/D converter (DigiData
1200 Series Interface). Field potentials may be evoked by
A- or C-fibres. The different components can easily be dis-
tinguished by their thresholds and latencies. C-fibre
evoked field potentials have high thresholds (> 5–6 V)
and long latencies (90 – 150 ms, corresponding to the
conduction velocity of < 1.2 m·s-1). The potentials were
not abolished by spinalisation or muscle relaxation,
strongly suggesting that these signals are evoked by activa-
tion of primary afferent C-fibres. This is in line with a
report by Schouenborg [8], suggesting that field potentials
are generated monosynaptically by synapses between pri-
mary afferent fibres and second order neurons. A polysy-
naptic contribution to the signals can, however, not be
fully excluded. As test stimuli, single pulses (0.5 ms, 25 V,
which is suprathreshold for the activation of C-fibres)
were delivered to the sciatic nerve every 5 minutes using
an electrical stimulator (Iso-Stim 01D, npi electronic, Ger-
many). Stable responses for 1 hour served as control. LTP
of C-fibre evoked field potentials was induced by low fre-
quency stimulation (LFS, 2 Hz, 0.1 ms pulses, 60 V, 2
min). After conditioning stimulation, test pulses were
applied again to the sciatic nerve at 5 min intervals for up
to 7 hours.
Rhodamine B (0.2%, Sigma) was added to the pipette
solution which consisted of (in mM) NaCl 135, KCl 5.4,
CaCl2 1.8, Hepes 10 and MgCl2 1. For identification of the
recording position, pressure was applied to the electrode
(300 mbar, 1 min) at the end of each electrophysiological
experiment. The spinal cord was removed, cryo-fixed and
the rhodamine B spot was localised under a fluorescence
microscope. Only those experiments where the tip of the
recording electrode was located in lamina I or II were
included into the study.
Drugs
Pancuronium bromide (Pancuronium-ratiopharm®, Rati-
opharm GmBH, Ulm, Germany) was given as an i.v. infu-
sion (2 μg·kg-1·h-1). The competitive N-methyl-D-
aspartate (NMDA) receptor antagonist D(-)-2-Amino-5-
phosphonopentanoic acid (D-AP5, 100 μM, Sigma) and
the T-type voltage-dependent Ca2+  channel (VDCC)
blocker mibefradil dihydrochloride hydrate (5 mM,
Sigma) were dissolved in 0.9% NaCl. The protein kinase
C (PKC) blocker chelerythrine chloride (800 μM, Sigma)
was dissolved in ddH2O. The Ca2+-calmodulin dependent
kinase II (CaMKII) blocker 2- [N-(2-hydroxyethyl)]-N-
(4methoxybenzenesulfonyl)]amino-N-(4-chlorocin-
namyl)-N-methylbenzylamine (KN-93, 400 μM, Sigma),
the phospholipase C (PLC) blocker 1- [6-[((17β)-3-Meth-
oxyestra-1,3,5[10]-trien-17-yl)amino]hexyl]-1H-pyrrole-
2,5-dione (U-73122, 500 μM, Sigma), the neurokinin
receptor 1 (NK1 receptor) blocker cis-2-(Diphenylme-Molecular Pain 2008, 4:18 http://www.molecularpain.com/content/4/1/18
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thyl)-N- [(2-iodophenyl)methyl]-1azabicyclo
[2.2.2]octan-3-amine oxalate salt (L-703,606, 5 mM,
Sigma) and the ryanodine receptor blocker dantrolene
(500 μM, Tocris) were dissolved in DMSO. Dantrolene
was further dissolved in standard solution titrated to a pH
of 9.5. All other drugs were further dissolved in artificial
cerebrospinal fluid to obtain desired concentrations as
indicated and applied directly onto the spinal cord [9],
starting 30 min prior LFS.
Data analysis and statistics
The area under the curve of C-fibre evoked field potentials
was determined offline using the software Clampfit 9.0
(Molecular Devices Inc.). For the electrophysiological
experiments, responses were normalised for each rat. A
one way repeated measures analysis of variance (One way
RM-ANOVA) was performed to compare the different
experimental protocols and treatments. ANOVA was cor-
rected by the Bonferroni adjustment. A p-value < 0.05 was
considered statistically significant. Values are expressed as
mean ± standard error of mean (SEM).
Results and discussion
Intact, adult rats were used in the present study to evaluate
LTP induction in vivo by low-level activity in C-fibres. Elec-
trical LFS (2 Hz, 2 min, C-fibre strength) delivered to the
sciatic nerve induced stable LTP of C-fibre evoked field
potentials always lasting until the end of the recording
period of up to 7 hours (Fig. 1A). LFS-induced mean LTP
of C-fibre evoked field potentials to 160% ± 13% of con-
trol (p < 0.05, n = 5) at 60 min after conditioning stimu-
lation (Fig 1B; Table 1). A-fibre evoked field potentials
were never affected (data not shown). In some subsequent
experiments DMSO was used as a solvent for drugs
applied directly onto the spinal cord surface. Superfusion
of the spinal cord at the recording segment with this sol-
vent had no effect on LTP induction in any of the 3 ani-
mals tested (Table 1).
We have shown previously that in vitro LFS-induced LTP
requires a rise in [Ca2+]i [4]. This may be achieved by Ca2+-
influx from the extracellular space or by release from intra-
cellular compartments [10]. During LFS, voltage-depend-
ent Ca2+  channels (VDCCs) which open already by
moderate depolarization, may be activated. To test if low-
voltage activated T-type VDCCs play a role, we applied the
blocker mibefradil (5 mM) directly onto the spinal cord
30 min prior to LFS. Topical mibefradil completely pre-
vented LTP induction (Fig. 2A; Table 1), suggesting that
LFS of sciatic C-fibres is sufficient to activate T-type
LTP in the spinal dorsal horn is induced by LFS of C-fibres in the sciatic nerve Figure 1
LTP in the spinal dorsal horn is induced by LFS of C-fibres in the sciatic nerve. Electrical LFS at C-fibre strength 
delivered to the sciatic nerve induced LTP of C-fibre evoked field potentials in laminae I/II of the spinal cord dorsal horn, lasting 
undiminished for several hours. A representative example of LFS-induced LTP and two original recordings prior to (1) or after 
LTP-induction (2) are shown in (A). Areas of C-fibre evoked field potentials were used to quantify synaptic strength (dashed 
areas in 1 and 2). Mean time course of five experiments is shown in (B). In both graphs, area of C-fibre evoked field potentials 
(% of control) is plotted against time (min). The arrows represent the time point of conditioning LFS.
-60 0 60 120 180 240 300 360 420
0
50
100
150
200
250
300
350 LFS
-60 -30 0 30 60
0
50
100
150
200
250 LFS
50 ms
1m V
1 2
1
2
A B
Time (min)
Area
of
C-fibre
evoked
field
potential
(%
of
control)Molecular Pain 2008, 4:18 http://www.molecularpain.com/content/4/1/18
Page 4 of 8
(page number not for citation purposes)
VDCCs in spinal cord, and that this contributes to LTP
induction. Our finding is in line with recent studies show-
ing that spinal T-type VDCCs play a role both for normal
nociception, and for thermal and mechanical hyperalge-
sia in models of neuropathic pain [11,12].
Upon stimulation substance P is released from C-fibre
afferents, leading to activation of neurokinin-1 (NK1)
receptors, mainly in laminae I/II neurons of the spinal
dorsal horn [13]. Most NK1-expressing lamina I neurons
have a supraspinal projection [14]. Blockade of spinal
NK1 receptors attenuates thermal and mechanical hyper-
algesia [15-17]. In the present study, blocking spinal NK1
receptors with L-703,606 (5 mM) not only fully blocked
LTP induction but rather led to LFS-induced LTD of C-
fibre evoked field potentials (Fig 2B; Table 1).
The thresholds for the induction of LTP and LTD have
been suggested to be tuned narrowly. Changes in the level
of elevation of [Ca2+]i might shift the threshold from LTP
towards LTD [18]. The polarity of synaptic plasticity fur-
ther depends upon the magnitude [19], the temporal pat-
tern [20] and the mode of postsynaptic Ca2+ elevation
[21]. These parameters are all relevant for activation of
distinct Ca2+-dependent signal transduction pathways
involving protein phosphatases and kinases. Interestingly,
blockade of NK1 receptors but not of VDCCs or NMDA
receptors (see below) might critically change at least one
of these characteristics of the rise in [Ca2+]i, shifting syn-
aptic plasticity from LTP towards LTD. This illustrates that
blocking different routes of [Ca2+]i rise may have differen-
tial effects on synaptic plasticity.
In superficial spinal dorsal horn neurons [Ca2+]i may be
increased by the release of Ca2+ from intracellular stores
[10] via activation of either ryanodine or inositol 1,4,5-tri-
sphosphate (IP3) receptors. Ryanodine receptors may be
activated by Ca2+ which may, for example, enter the cell
through VDCCs, leading to Ca2+-induced Ca2+  release
from ryanodine sensitive stores [10]. In the present study,
spinal ryanodine receptors were blocked by dantrolene
(500 μM), a clinically used ryanodine receptor antagonist.
This abolished LTP induction in all animals tested (Fig
2C; Table 1). Intrathecal injection of dantrolene has pre-
viously been shown to reduce nociceptive behaviour
caused by spinal application of a NK1 receptor agonist
[22].
Another trigger for Ca2+ release from intracellular stores is
the activation of IP3 receptors. IP3 receptors are activated
by IP3, a product formed by hydrolysis of phosphatidyli-
nositol 4,5 bisphosphate upon activation of the phosph-
oinosite system. It starts with activation of phospholipase
C (PLC) by the alpha subunit of a Gq-protein [23]. Activa-
tion of PLC in the spinal cord is essential for hyperalgesia.
For example, mechanical hyperalgesia induced by intra-
plantar injection of endothelin 1, a peptide produced by
many different cell types, requires activation of spinal PLC
[24]. Furthermore, intrathecal pre-treatment with a PLC
inhibitor reduced the second-phase in the formalin test
[25]. In the present study, inhibition of PLC in spinal cord
by the selective blocker U-73122 (500 μM) completely
prevented induction of LTP by LFS (Fig. 2D; Table 1).
PLC activation also leads to the production diacylglycerol
(DAG) which in turn activates protein kinase C (PKC). At
least 12 isoforms of this enzyme can be distinguished,
many of those are present in superficial laminae of the spi-
nal cord dorsal horn [26]. PKC plays a crucial role in the
development of hyperalgesia. Activation of spinal PKC by
phorbol esters evokes thermal hyperalgesia and mechani-
cal allodynia in awake rats [27]. An involvement of PKC
in inflammatory pain has also been shown. For example,
PKC inhibitors attenuate hyperalgesia after intradermal
injection of capsaicin or formalin [28,29]. PKC may phos-
phorylate the NMDA receptor at distinct phosphorylation
sites, thereby increasing channel activity [30,31] or
removing the Mg2+ block [32]. Here, blockade of spinal
PKC by chelerythrine (800 μM) abolished induction of
LTP by LFS in all animals tested (Fig. 2E; Table 1).
Activation of Ca2+-permeable NMDA receptors in spinal
dorsal horn is an essential step for the induction of several
forms of hyperalgesia and allodynia [33-35]. However,
NMDA receptors are normally blocked near the resting
membrane potential by Mg2+. One might speculate that
LFS is not sufficient to activate NMDA receptors, unless
the Mg2+ block is removed e.g. by phosphorylation via
PKC. And indeed, LFS-induced LTP required activation of
NMDA receptors, as blockade of spinal NMDA receptors
with the competitive NMDA receptor antagonist D-AP5
(100 μM) prevented LTP induction (Fig 2F; Table 1). This
Table 1: Summary of results
Superfusate Concentration C-fibre response (% control) n
ACSF - 160% ± 13%* 5
DMSO 25% 150% ± 14%* 3
Mibefradil 5 mM 108% ± 14% n.s. 5
L-703,606 5 mM 88% ± 15%* 5
Dantrolene 500 μM1 0 3 %  ±  1 4 %  n . s . 5
U-73122 500 μM1 0 7 %  ±  1 0 %  n . s . 5
Chelerythrine 800 μM 103% ± 7% n.s. 5
D-AP5 100 μM 107% ± 8% n.s 5
KN-93 400 μM 99% ± 5% n.s 5
Mean (± SEM) C-fibre evoked field potentials are expressed as % of 
control 60 min after LFS. One-way repeated measure-ANOVA was 
used to compare areas of C-fibre evoked field potentials before and 
after LFS. The asterisk denotes significant differences from baseline (* 
= p < 0.05). Drugs in spinal superfusate and their respective 
concentrations are indicated.Molecular Pain 2008, 4:18 http://www.molecularpain.com/content/4/1/18
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Signalling pathways underlying the induction of LFS-induced LTP in vivo Figure 2
Signalling pathways underlying the induction of LFS-induced LTP in vivo. In all graphs, area of C-fibre evoked field 
potentials (% of control) is plotted against time (min). Data are expressed as mean ± SEM (n = 5 for all groups). Spinal super-
fusion at the recording segment with the T-type VDCC blocker mibefradil (5 mM, A), the ryanodine receptor blocker dantro-
lene (500 μM, C), the PLC inhibitor U-73122 (500 μM, D), the PKC blocker chelerythrine (800 μM, E), the NMDA receptor 
blocker D-AP5 (100 μM, F) or the CaMKII blocker KN-93 (400 μM, G) fully blocked LTP induction by LFS. Blockade of spinal 
NK1 receptors with L-703,606 led to induction of LTD rather than LTP by LFS (B). See also Table 1.
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Potential mechanisms of LTP in spinal dorsal horn in vivo Figure 3
Potential mechanisms of LTP in spinal dorsal horn in vivo. At synapses between C-fibres and laminae I/II second order 
neurons, LFS triggers the release of the excitatory neurotransmitters glutamate and substance P leading to depolarization of 
the postsynaptic cell (1). T-type VDCCs are activated (2), leading to Ca2+ influx. The activation of NK1 receptors (3) activates 
the PLC-pathway (4), triggering the release of Ca2+ from intracellular stores (5) and the activation of PKC (6). This kinase phos-
phorylates NMDA receptors, thereby loosening their Mg2+ block (7). Ca2+-induced Ca2+ release activates ryanodine receptors, 
thereby further increasing [Ca2+]i (8). The increased [Ca2+]i is sensed by CaMKII that phosphorylates AMPA receptors, thereby 
potentiating synaptic strength. LFS: low frequency stimulation; SP: substance P; VDCC: voltage-dependent Ca2+ channel; 
AMPAR: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; NMDAR: N-methyl-D-aspartate receptor; 
NK1R: neurokinin receptor 1; PLC: phospholipase C; PKC: protein kinase C; IP3R: inositol 1,4,5-trisphosphate receptor; RyR: 
ryanodine receptor; CaMKII: Ca2+-calmodulin dependent kinase II;
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is similar to findings of previous studies showing that
NMDA receptor activation is also required for high fre-
quency stimulation (HFS)-induced LTP in the spinal cord
dorsal horn [36-38,3].
A rise in [Ca2+]i may lead to Ca2+ binding to calmodulin,
which in turn activates Ca2+-calmodulin dependent
kinase II (CaMKII). CaMKII undergoes a Ca2+-dependent
autophosphorylation, resulting in Ca2+-independent
activity [39]. One of its main targets is the GluR1 subunit
of the AMPA receptor, which gets phosphorylated at
Ser831 [40]. This leads to an increased channel conduct-
ance and thus synaptic strength [41]. Activation of spinal
CaMKII is required for some forms of hyperalgesia [42-
44]. For example, intrathecal pre-treatment with a CaMKII
inhibitor prevents thermal hyperalgesia and mechanical
allodynia after injection of complete Freund's adjuvant
into a hindpaw [45]. Inhibition of CaMKII blocks induc-
tion of HFS-induced LTP in the spinal cord dorsal horn
[46].
Here, the CaMKII inhibitor KN-93 (400 μM) abolished
induction of LFS-induced LTP in all animals tested (Fig
2G; Table 1).
Conclusion
In the present study, we investigated signal transduction
mechanisms underlying LFS-induced LTP in the spinal
cord in vivo. We could show that pathways required for
LTP induction match those involved in hyperalgesia. This
suggests that LFS-induced LTP at spinal synapses of C-
fibres may be a mechanism of pain amplification in
behaving animals and perhaps human subjects [47].
Conditioning electrical stimulation of C-fibres at low fre-
quencies induces LTP at the first nociceptive synapses in
the spinal cord dorsal horn in slice preparations as well as
in intact animals [[4], present study]. The signal transduc-
tion pathways underlying this novel form of LTP have
been previously investigated in vitro only [4]. Here we
demonstrate that pathways underlying the induction of
LFS-induced LTP in vivo fully match those in the in vitro
slice preparation suggesting that the same cellular ele-
ments are involved despite the very different experimental
conditions. The absence or presence of descending modu-
latory pathways or general anaesthesia does apparently
not affect the principle mechanisms of LFS-induced syn-
aptic plasticity in superficial spinal dorsal horn.
Based on the results of the present study, the following
sequence of events leading to the induction of LTP at syn-
apses of primary afferent C-fibres can be suggested (Fig.
3): LFS of the sciatic nerve triggers the release of excitatory
neurotransmitters including glutamate and substance P
(1.), which leads to a moderate depolarization of postsy-
naptic neurons. This is sufficient to activate low-voltage
activated T-type Ca2+ channels and Ca2+ influx into the cell
(2.). In addition, NK1 receptors are activated (3.). Down-
stream to this receptor activation, the PLC-pathway (4.)
leads to the release of Ca2+ from intracellular stores (5.) as
well as to activation of PKC (6.). This kinase phosphor-
ylates the NMDA receptor (7.), thereby reducing its Mg2+
block. By this, moderate postsynaptic depolarization may
become sufficient to open NMDA receptor channels, lead-
ing to an additional influx of Ca2+. [Ca2+]i rise is further
enhanced by Ca2+-induced Ca2+ release from ryanodine
sensitive stores (8.). CaMKII is activated by an increased
[Ca2+]i  and phosphorylates AMPA receptors, thereby
increasing their channel conductance. Its activity is also
necessary for translocation of AMPA receptors to the sub-
synaptic membrane [48]. This ultimately results in an
increased strength of excitatory synapses in nociceptive
pathways (9.) and amplification of nociception and per-
haps pain perception.
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